Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP-101
UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, announced receipt... Read More
